BCL2 and lymphoma: In the cases of DLBCLs, 3 triple expressor lymphoma cases and 7 double expressor lymphoma cases were identified by the co-expression of cMYC, BCL2, and BCL6 (cutoff points for expression of cMYC protein (≥ 40%), BCL2 protein (≥ 50%), BCL6 protein (≥ 50%)).